Literature DB >> 16314029

Drug treatment for LUTS and BPH: new is not always better.

Claus G Roehrborn.   

Abstract

Mesh：

Year:  2005        PMID： 16314029     DOI： 10.1016/j.eururo.2005.10.005

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.

Authors:  K Höfner; M Burkart; G Jacob; U Jonas
Journal:  World J Urol       Date:  2009-12-10       Impact factor: 4.226

2.  Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder.

Authors:  Jun-Wei Gai; Wasilijiang Wahafu; Hui Guo; Miao Liu; Xu-Chang Wang; Yun-Xiang Xiao; Liang Zhang; Zhong-Cheng Xin; Jie Jin
Journal:  Asian J Androl       Date:  2013-06-03       Impact factor: 3.285

3.  Various treatment options for benign prostatic hyperplasia: A current update.

Authors:  Alankar Shrivastava; Vipin B Gupta
Journal:  J Midlife Health       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.